Last $22.26 USD
Change Today +0.35 / 1.60%
Volume 29.8K
EPZM On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 11:06 AM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Eric E. Hedrick M.D.

Advisor, Epizyme, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

49$566,915
As of Fiscal Year 2013

Background*

Dr. Eric E. Hedrick, M.D. has been an Advisor of Epizyme, Inc. since October 31, 2014. Dr. Hedrick served as the Chief Medical Officer of Epizyme, Inc. from May 2012 to October 31, 2014. Dr. Hedrick served as an Interim Chief Medical Officer of Pharmacyclics Inc. since May 2011 and served as its Vice President of Oncology Development from August 2010 to April 2012. From October 2009 to August 2010, Dr. Hedrick was an independent drug development consultant, including ...

Read Full Background

Corporate Headquarters*

400 Technology Square
Cambridge, Massachusetts 02139

United States

Phone: 617-229-5872
Fax: 617-349-0707

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
Boston University
MD
University of Maryland School of Medicine

Other Affiliations*

Annual Compensation*

Salary$370,800
Bonus$92,700
Total Annual Compensation$463,500

Stock Options*

All Other Compensation$103,415
Exercisable Options118,750
Unexercisable Options181,250
Total Number of Options300,000

Total Compensation*

Total Annual Cash Compensation$566,915
Total Short Term Compensation$463,500
Other Long Term Compensation$103,415
Total Calculated Compensation$566,915
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EPZM:US $22.26 USD +0.35

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EPIZYME INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.